0 CHECKOUT

PRODUCT FILTERS

REGION

4
2
2
2

COUNTRY

CATEGORIES

  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
1
1
6

PUBLISHED

0
1
1
6

PRODUCT TYPE

Search for: "The 2011-2016 Outlook for Over-The-Counter Generic Drugs in Japan"

Intranasal Drug Delivery - Global Strategic Business Report

This report analyzes the US market for Intranasal Drug Delivery in US$ Million by the following Therapeutic Areas: Allergic Infections, Analgesics, Osteoporosis, and Vaccinations. Annual estimates and...

Published:  May 2016
Price:  From

Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players

GBI Research, the leading business intelligence provider, has released its latest research “Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign...

Published:  April 2013
Price:  From

Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs Market

The present report entitled “Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs Market”, discuss market size (historical, present and future) of the Japanese pharmaceutical...

Published:  January 2012
Price:  From

PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022 Summary Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022....

Published:  January 2013
Price:  From

PharmaPoint: HIV - Global Drug Forecast and Market Analysis to 2022 Event Driven Update

PharmaPoint: HIV - Global Drug Forecast and Market Analysis to 2022 Event Driven Update Summary Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since...

Published:  March 2013
Price:  From

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 Summary The lupus therapeutics market is dominated by generics and GlaxoSmithKline’s...

Published:  October 2013
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group